A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Ovarian Cancer
Interventions: DRUG: 6-Mercaptopurine|DRUG: Methotrexate
Sponsor: University of Oxford